Psoriatic Disease

Psoriatic Disease
J&J withMe in your country
The Immune System

The immune system is your body’s defence against disease and pathogens. In immune-mediated inflammatory diseases, the immune system wrongly attacks its own tissues and causes inflammation, pain, and can result in loss of function.

At Johnson & Johnson, we are focusing our scientific expertise on creating ways to restore the body’s immune balance. We’re committed to discovering new medicines that will redefine the way we maintain immune-mediated health.

Johnson & Johnson and Psoriatic Disease

Johnson & Johnson’s worldwide leadership in immunology has been established from a 30-year heritage of innovation and scientific breakthroughs. For over two decades, we have been a world leader in the development of biologic treatments that have modified the imbalance in patients’ immune systems and have transformed their lives.

We foster active collaborations with academia, emerging companies, patients, and patient groups to accelerate innovation and achieve our shared goals in tackling immune-mediated disease.

Explore our Disease Areas

Psoriasis (Pso)

Psoriasis is an immune system-related skin disorder. It can manifest in a few different ways and can appear anywhere on your body, often in itchy, sometimes painful, red patches or silvery scales. It can also cause thick, pitted or ridged nails. Approximately 30% of people who have Pso later develop PsA (see below).

Psoriatic Arthritis (PsA)

Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory disease that affects the joints. It is a form of arthritis that affects some people who have psoriasis, though some people never develop psoriasis, or develop PsA first. The most common symptoms of PsA are pain, stiffness and swelling in your joints.

References

International Waldenstrom’s Macroglobulinemia Foundation. Living with Waldenstrom’s Macroglobulinemia. Available at: https://iwmf.com/living-with-wm/. Last accessed: February 2025.
Dana-Farber Cancer Institute. Waldenström's Macroglobulinemia. Available at: https://www.dana-farber.org/waldenstroms-macroglobulinemia/about/. Last accessed: February 2025.
American Cancer Society. What Is Non-Hodgkin Lymphoma? Availabe at: https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/what-is-non-hodgkin-lymphoma.html. Last accessed: February 2025.
National Cancer Institute. B lymphocyte. Available at: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-lymphocyte. Last accessed: February 2025.
Mayo Clinic. Waldenstrom macroglobulinemia. Available at: https://www.mayoclinic.org/diseases-conditions/waldenstrom-macroglobulinemia/symptoms-causes/syc-20359967. Last accessed: February 2025.
Janssen. Waldenström’s Macroglobulinemia (WM) infographic. Available at: https://www.janssen.com/emea/sites/www_janssen_com_emea/files/multimedia/wm_infographic_janssen_consumer_logo_final_2017_05_03.pdf. Last accessed: February 2025.
American Cancer Society. Signs and symptoms of Waldenstrom Macroglobulinemia. Available at: https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/detection-diagnosis-staging/signs-symptoms.html. Last accessed: February 2025.
University College London Hospitals – NHS Foundation Trust. What is Waldenström’s macroglobulinaemia? Available at: https://www.uclh.nhs.uk/our-services/find-service/cancer-services/waldenstroms-macroglobulinemia-1/what-waldenstroms-macroglobulinaemia. Last accessed: February 2025.
American Cancer Society. Tests for Waldenstrom Macroglobulinemia. Available at: https://www.cancer.net/cancer-types/waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma/diagnosis. Last accessed: February 2025.
University College London Hospitals – NHS Foundation Trust. Diagnosing Waldenström’s macroglobulinaemia. Available at: https://www.uclh.nhs.uk/our-services/find-service/cancer-services/waldenstroms-macroglobulinemia-1/diagnosing-waldenstroms-macroglobulinaemia. Last accessed: February 2025.
Buske C, et al. Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(S6):vi155-vi159.
American Cancer Society. What Are the Risk Factors for Waldenstrom Macroglobulinemia? Available at: https://www.cancer.net/cancer-types/waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma/risk-factors. Last accessed: February 2025.
American Cancer Society. Waldenstrom Macroglobulinemia Stages. Available at: https://www.cancer.net/cancer-types/waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma/stages. Last accessed: February 2025.
Dana-Farber Cancer Institute. How We Treat Waldenström's Macroglobulinemia. Available at: https://www.dana-farber.org/waldenstroms-macroglobulinemia/treatment/. Last accessed: February 2025.
American Cancer Society. Treating Waldenstrom Macroglobulinemia. Available at: https://www.cancer.net/cancer-types/waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma/types-treatment. Last accessed: February 2025.
American Cancer Society. Vaccinations and Flu Shots for People with Cancer. Available at: https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/low-blood-counts/infections/vaccination-during-cancer-treatment.html. Last accessed: February 2025.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson